DC
Davenport & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100M | Buy |
226,184
+874
| +0.4% | +$388K | 0.55% | 60 |
|
|
2025
Q1 | $110M | Buy |
225,310
+7,242
| +3% | +$3.52M | 0.64% | 49 |
|
|
2024
Q4 | $87.6M | Sell |
218,068
-1,641
| -0.7% | -$660K | 0.5% | 68 |
|
|
2024
Q3 | $102M | Sell |
219,709
-1,816
| -0.8% | -$844K | 0.58% | 57 |
|
|
2024
Q2 | $104M | Buy |
221,525
+2,734
| +1% | +$1.28M | 0.63% | 45 |
|
|
2024
Q1 | $91.3M | Sell |
218,791
-447
| -0.2% | -$187K | 0.56% | 58 |
|
|
2023
Q4 | $89.3M | Buy |
219,238
+103,769
| +90% | +$42.2M | 0.61% | 56 |
|
|
2023
Q3 | $40.3M | Sell |
115,469
-442
| -0.4% | -$154K | 0.3% | 98 |
|
|
2023
Q2 | $40.7M | Buy |
115,911
+101,567
| +708% | +$35.7M | 0.3% | 96 |
|
|
2023
Q1 | $4.52M | Sell |
14,344
-394
| -3% | -$124K | 0.04% | 278 |
|
|
2022
Q4 | $4.26M | Buy |
14,738
+157
| +1% | +$45.3K | 0.03% | 270 |
|
|
2022
Q3 | $4.22M | Sell |
14,581
-6,284
| -30% | -$1.82M | 0.04% | 260 |
|
|
2022
Q2 | $5.88M | Sell |
20,865
-1,405
| -6% | -$396K | 0.05% | 220 |
|
|
2022
Q1 | $5.81M | Buy |
22,270
+1,553
| +7% | +$405K | 0.04% | 243 |
|
|
2021
Q4 | $4.55M | Buy |
20,717
+2,318
| +13% | +$509K | 0.03% | 269 |
|
|
2021
Q3 | $3.34M | Buy |
18,399
+1,272
| +7% | +$231K | 0.02% | 302 |
|
|
2021
Q2 | $3.45M | Sell |
17,127
-124,507
| -88% | -$25.1M | 0.03% | 262 |
|
|
2021
Q1 | $30.4M | Buy |
141,634
+8,598
| +6% | +$1.85M | 0.29% | 94 |
|
|
2020
Q4 | $31.4M | Buy |
133,036
+131,123
| +6,854% | +$31M | 0.31% | 91 |
|
|
2020
Q3 | $521K | Buy |
+1,913
| New | +$521K | 0.01% | 453 |
|